Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4049.0
(-2.03%)
JPY 4049.0
(-2.03%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 8.02 Billion JPY | 47.52% |
| 2022 | 5.44 Billion JPY | -43.03% |
| 2021 | 9.54 Billion JPY | -28.77% |
| 2020 | 13.4 Billion JPY | -30.8% |
| 2019 | 19.37 Billion JPY | 8.97% |
| 2018 | 17.77 Billion JPY | -6.66% |
| 2017 | 19.04 Billion JPY | -13.51% |
| 2016 | 22.01 Billion JPY | 4.13% |
| 2015 | 21.14 Billion JPY | 74.42% |
| 2014 | 12.12 Billion JPY | 24.52% |
| 2013 | 9.73 Billion JPY | 8.27% |
| 2012 | 8.99 Billion JPY | 8.56% |
| 2011 | 8.28 Billion JPY | 0.84% |
| 2010 | 8.21 Billion JPY | 21.96% |
| 2009 | 6.73 Billion JPY | 20.7% |
| 2008 | 5.57 Billion JPY | 9.26% |
| 2007 | 5.1 Billion JPY | 10.95% |
| 2006 | 4.6 Billion JPY | 18.43% |
| 2005 | 3.88 Billion JPY | 13.73% |
| 2004 | 3.41 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.75 Billion JPY | 167.67% |
| 2023 Q1 | 2.51 Billion JPY | 167.67% |
| 2023 FY | 8.02 Billion JPY | 47.52% |
| 2023 Q4 | 1.35 Billion JPY | -48.22% |
| 2023 Q3 | 2.6 Billion JPY | 67.33% |
| 2023 Q2 | 1.55 Billion JPY | -37.93% |
| 2022 Q4 | -3.7 Billion JPY | -216.45% |
| 2022 Q1 | 2.9 Billion JPY | 517.07% |
| 2022 Q2 | 3.05 Billion JPY | 5.16% |
| 2022 Q3 | 3.18 Billion JPY | 4.19% |
| 2022 FY | 5.44 Billion JPY | -43.03% |
| 2021 Q1 | 3.36 Billion JPY | 36.06% |
| 2021 Q2 | 3.35 Billion JPY | -0.09% |
| 2021 Q3 | 3.52 Billion JPY | 4.94% |
| 2021 Q4 | -697 Million JPY | -119.77% |
| 2021 FY | 9.54 Billion JPY | -28.77% |
| 2020 Q3 | 3.7 Billion JPY | 8.87% |
| 2020 FY | 13.4 Billion JPY | -30.8% |
| 2020 Q2 | 3.4 Billion JPY | -10.84% |
| 2020 Q1 | 3.82 Billion JPY | 0.1% |
| 2020 Q4 | 2.47 Billion JPY | -33.36% |
| 2019 Q4 | 3.81 Billion JPY | -36.47% |
| 2019 Q1 | 4.82 Billion JPY | 36.79% |
| 2019 Q2 | 4.72 Billion JPY | -2.18% |
| 2019 Q3 | 6 Billion JPY | 27.24% |
| 2019 FY | 19.37 Billion JPY | 8.97% |
| 2018 FY | 17.77 Billion JPY | -6.66% |
| 2018 Q4 | 3.52 Billion JPY | -34.75% |
| 2018 Q3 | 5.4 Billion JPY | 12.53% |
| 2018 Q1 | 4.03 Billion JPY | 84.75% |
| 2018 Q2 | 4.8 Billion JPY | 19.08% |
| 2017 Q2 | 5.4 Billion JPY | -1.06% |
| 2017 Q4 | 2.18 Billion JPY | -63.55% |
| 2017 Q3 | 5.99 Billion JPY | 10.84% |
| 2017 Q1 | 5.46 Billion JPY | 35.42% |
| 2017 FY | 19.04 Billion JPY | -13.51% |
| 2016 Q2 | 5.65 Billion JPY | -2.52% |
| 2016 Q3 | 6.53 Billion JPY | 15.7% |
| 2016 Q4 | 4.03 Billion JPY | -38.29% |
| 2016 FY | 22.01 Billion JPY | 4.13% |
| 2016 Q1 | 5.79 Billion JPY | 474.43% |
| 2015 Q3 | 7.65 Billion JPY | 23.74% |
| 2015 Q4 | 1 Billion JPY | -86.81% |
| 2015 FY | 21.14 Billion JPY | 74.42% |
| 2015 Q2 | 6.18 Billion JPY | -1.86% |
| 2015 Q1 | 6.3 Billion JPY | 150.3% |
| 2014 Q2 | 3 Billion JPY | 14.41% |
| 2014 Q3 | 3.96 Billion JPY | 31.8% |
| 2014 Q4 | 2.51 Billion JPY | -36.54% |
| 2014 FY | 12.12 Billion JPY | 24.52% |
| 2014 Q1 | 2.63 Billion JPY | 14.15% |
| 2013 Q4 | 2.3 Billion JPY | -18.67% |
| 2013 FY | 9.73 Billion JPY | 8.27% |
| 2013 Q1 | 2.2 Billion JPY | 37.0% |
| 2013 Q2 | 2.39 Billion JPY | 8.34% |
| 2013 Q3 | 2.83 Billion JPY | 18.49% |
| 2012 Q2 | 2.51 Billion JPY | 19.6% |
| 2012 FY | 8.99 Billion JPY | 8.56% |
| 2012 Q1 | 2.1 Billion JPY | 29.27% |
| 2012 Q3 | 2.76 Billion JPY | 9.94% |
| 2012 Q4 | 1.61 Billion JPY | -41.71% |
| 2011 Q4 | 1.62 Billion JPY | -20.64% |
| 2011 Q1 | 2.18 Billion JPY | 80.76% |
| 2011 Q2 | 2.42 Billion JPY | 11.33% |
| 2011 Q3 | 2.04 Billion JPY | -15.57% |
| 2011 FY | 8.28 Billion JPY | 0.84% |
| 2010 Q1 | 2.42 Billion JPY | 285.99% |
| 2010 Q4 | 1.2 Billion JPY | -56.4% |
| 2010 Q3 | 2.76 Billion JPY | 52.31% |
| 2010 Q2 | 1.81 Billion JPY | -25.08% |
| 2010 FY | 8.21 Billion JPY | 21.96% |
| 2009 Q2 | 1.8 Billion JPY | 6.04% |
| 2009 Q3 | 2.59 Billion JPY | 43.17% |
| 2009 Q4 | 628 Million JPY | -75.75% |
| 2009 FY | 6.73 Billion JPY | 20.7% |
| 2009 Q1 | 1.7 Billion JPY | 453.9% |
| 2008 Q4 | 308 Million JPY | -83.44% |
| 2008 FY | 5.57 Billion JPY | 9.26% |
| 2008 Q3 | 1.86 Billion JPY | 12.32% |
| 2008 Q2 | 1.65 Billion JPY | 0.0% |
| 2007 FY | 5.1 Billion JPY | 10.95% |
| 2006 FY | 4.6 Billion JPY | 18.43% |
| 2005 FY | 3.88 Billion JPY | 13.73% |
| 2004 FY | 3.41 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -150.39% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 94.43% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 102.548% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 95.047% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -7265.156% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 68.957% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 81.076% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -1051.363% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 42.551% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -76.49% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -482.789% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 4558.333% |
| Tsumura & Co. | 16.7 Billion JPY | 51.966% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 28.091% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -94.829% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 50.38% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -133.624% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -3.799% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -50.789% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 263.976% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -143.551% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 508.851% |
| MedRx Co., Ltd | -932 Million JPY | 961.052% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -112.626% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 821.673% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 435.518% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -6.362% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 41.402% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 1461.991% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 61.151% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -172.372% |